Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-01

Clinical Trial Update: Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety, pharmacodynamics, and pharmacokinetics of the IV study drug QN-302 in patients with advanced or metastatic soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QN-302

Snippet

Sponsor: Qualigen Theraputics, Inc. | Conditions: Solid Tumor | Phase 1 | Status: RECRUITING